Increased endothelin-1 and diminished nitric oxide levels in blister fluids of patients with intermediate cold type complex regional pain syndrome type 1.
about
The NALP1 inflammasome controls cytokine production and nociception in a rat fracture model of complex regional pain syndromeRegulation of peripheral blood flow in complex regional pain syndrome: clinical implication for symptomatic relief and pain management.Activation of cutaneous immune responses in complex regional pain syndrome.Clinical features and pathophysiology of complex regional pain syndrome.The use of ketamine in complex regional pain syndrome: possible mechanisms.Efficacy and safety of ketamine in patients with complex regional pain syndrome: a systematic review.Morphological macrovascular alterations in complex regional pain syndrome type I demonstrated by increased intima-media thickness.Skin matters: identifying pain mechanisms and predicting treatment outcomes.A hypothesis for the cause of complex regional pain syndrome-type I (reflex sympathetic dystrophy): pain due to deep-tissue microvascular pathologySystemic inflammatory mediators in post-traumatic complex regional pain syndrome (CRPS I) - longitudinal investigations and differences to control groups.Remote ischaemic conditioning decreases blood flow and improves oxygen extraction in patients with early complex regional pain syndrome.New Concepts in Complex Regional Pain Syndrome.Correlations between plasma endothelin-1 levels and breakthrough pain in patients with cancer.Inflammation in complex regional pain syndrome: a systematic review and meta-analysisSix years follow-up of the levels of TNF-alpha and IL-6 in patients with complex regional pain syndrome type 1.Expression of endothelial nitric oxide synthase and endothelin-1 in skin tissue from amputated limbs of patients with complex regional pain syndrome.Algodystrophy in major orthopaedic surgery.Applied information retrieval and multidisciplinary research: new mechanistic hypotheses in complex regional pain syndromeEffect of anti-NGF antibodies in a rat tibia fracture model of complex regional pain syndrome type I.The role of enhanced cutaneous IL-1beta signaling in a rat tibia fracture model of complex regional pain syndrome.Relationship Between HbA1c and Complex Regional Pain Syndrome in Stroke Patients With Type 2 Diabetes Mellitus.Complex regional pain syndromes: new pathophysiological concepts and therapies.New perspectives on the endothelin axis in pain.Imaging and clinical evidence of sensorimotor problems in CRPS: utilizing novel treatment approaches.Pathophysiological Mechanisms Involved in Vasomotor Disturbances in Complex Regional Pain Syndrome and Implications for Therapy: A Review.Molecular signature of complex regional pain syndrome (CRPS) and its analysis.The Treatment of Longstanding Complex Regional Pain Syndrome with Oral Steroids.Stimulation of dorsal root ganglia for the management of complex regional pain syndrome: a prospective case series.Bisphosphonates Inhibit Pain, Bone Loss, and Inflammation in a Rat Tibia Fracture Model of Complex Regional Pain Syndrome.Complex regional pain syndrome: what's in a name?Altered sensitivity to mechanical stimulation during prolonged subcutaneous administration of endothelin-1 in rats.Rats with chronic post-ischemia pain exhibit an analgesic sensitivity profile similar to human patients with complex regional pain syndrome--type I.Role of peripheral endothelin receptors in an animal model of complex regional pain syndrome type 1 (CRPS-I)Radiofrequency ablation of stellate ganglion in a patient with complex regional pain syndrome.Keratinocyte expression of inflammatory mediators plays a crucial role in substance P-induced acute and chronic pain.Fracture induces keratinocyte activation, proliferation, and expression of pro-nociceptive inflammatory mediatorsRestoration of endothelin-1-induced impairment in endothelium-dependent relaxation by interleukin-10 in murine aortic rings.Pathophysiology of the spreading of complex regional pain syndrome revisited: a case report.Increased plasma glutamate, glycine, and arginine levels in complex regional pain syndrome type 1.Passive transfer autoimmunity in a mouse model of complex regional pain syndrome.
P2860
Q28568698-AEE50F74-7EE7-4797-B262-E1BAFC59BE78Q33506195-FF8F5DCD-EE2E-42AC-A288-F32D50B9019BQ33573783-0A2AA5D5-CA5C-461A-94AC-3A16780228E9Q33906895-4D36537F-1C80-4CCD-87BF-A2F0D49728D9Q34182127-27683096-3773-4B59-B620-F1F032F51CA5Q34237650-9327CD51-A499-4AB5-8DB7-8F67E6BECC95Q34577386-AF595D1A-A25E-40B1-A2F0-E39C621A93F4Q34772985-49ED0799-2EC8-458D-A233-B2306B462BF7Q35744066-88FB3740-1FF1-4E80-B515-CDCFF1A200C2Q35959448-F144CDB5-1C2A-4A12-B033-789C76940D4EQ36322340-FAB7EAFB-B57E-4D6D-80E0-3CC181743CA7Q36327294-91A9D96A-8A9B-4011-B329-A0D81AA0F868Q36368292-5D9FB2DC-E118-4604-965D-189CD722D6DFQ36659427-5BE98382-63B7-413B-993E-56A28AC12CA9Q36739973-BE6941D7-04AC-44B5-9FC9-09F3081BB5DFQ36777776-9E5F3BE6-2707-4E27-B3DE-CE37A066726FQ36800205-090A4B12-A164-457B-B17B-89F782BAF45DQ36811556-F41633C4-4D0B-4BF8-A9DD-2BB153DAFB4CQ36881864-4721A495-9B06-4282-9772-46B4E444C840Q37345168-D8A14E88-51AF-46DC-8659-6347E96B0721Q37413265-A616F697-3AB0-48D0-BB92-CE9D854CB19FQ37697878-80A961C1-6B61-49C9-A3FA-4CA58412CD4EQ37847276-CCC2399C-DB8F-4CF7-83C6-97241665C610Q38051126-C2D7B579-8C71-47D4-8BB6-830D8C3AE43FQ38627802-2352C53E-8D0B-4AA7-9665-895FB583F400Q38643270-0C93585E-89A9-4E4B-BD3B-4B1224C6138FQ39177567-4FCEBAAD-5C97-4A2E-B50B-7365E23D434CQ39213150-3CF0402C-EAF2-484A-81A6-FA2D425FFC88Q39381651-60DEDB46-DA4D-40AC-AF0A-A1611CE303A9Q40782545-AD37D007-06A1-4A09-9ABA-E13713FD863EQ41244486-F3C8A868-DE69-4E6B-A68C-1C572CF1D788Q41361350-648088D2-A9DD-427A-AF57-B845E7FB660EQ41813322-D9F42C16-8161-4E29-B0EF-B32F2B4922B4Q42131447-85E2155F-A76B-405D-BA83-80289A56EA5BQ42181344-655BEC5B-56E9-4BBA-93A0-AF0D534BBD51Q42382574-22B3E385-B5FA-4BAC-9903-D1D10CF1CD23Q42580035-B37589CB-74E0-4668-88F4-23827BD8006EQ45305741-0EA77CC6-4111-4E83-9DD1-68B392651EE1Q46639229-EF8D4D23-9845-4DB3-83CC-30863BA0BCBBQ47254079-05D203A0-377F-4430-9D38-366012718117
P2860
Increased endothelin-1 and diminished nitric oxide levels in blister fluids of patients with intermediate cold type complex regional pain syndrome type 1.
description
2006 nî lūn-bûn
@nan
2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Increased endothelin-1 and dim ...... regional pain syndrome type 1.
@ast
Increased endothelin-1 and dim ...... regional pain syndrome type 1.
@en
Increased endothelin-1 and dim ...... regional pain syndrome type 1.
@nl
type
label
Increased endothelin-1 and dim ...... regional pain syndrome type 1.
@ast
Increased endothelin-1 and dim ...... regional pain syndrome type 1.
@en
Increased endothelin-1 and dim ...... regional pain syndrome type 1.
@nl
prefLabel
Increased endothelin-1 and dim ...... regional pain syndrome type 1.
@ast
Increased endothelin-1 and dim ...... regional pain syndrome type 1.
@en
Increased endothelin-1 and dim ...... regional pain syndrome type 1.
@nl
P2093
P2860
P356
P1476
Increased endothelin-1 and dim ...... regional pain syndrome type 1
@en
P2093
Claudia Heijmans-Antonissen
Frank J P M Huygen
Freek J Zijlstra
Sjoerd Niehof
P2860
P2888
P356
10.1186/1471-2474-7-91
P577
2006-11-30T00:00:00Z
P5875
P6179
1017970803